Ironwood Pharmaceuticals (IRWD) EBT (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted EBT of $65.2 million for Q1 2026, up 140.56% sequentially from -$160.7 million in Q4 2025, and up 279.68% YoY from $17.2 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) EBT (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported EBT for 17 years, with the latest figure at $65.2 million in Q1 2026.
- Quarterly EBT rose 279.68% year-over-year to $65.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (down 91.81% YoY) and the FY2025 annual result came in at -$91.1 million, down 154.54% from the prior year.
- EBT improved to $65.2 million in Q1 2026 per IRWD's latest filing, from -$160.7 million in the prior quarter.
- Over five years, EBT peaked at $125.9 million in Q4 2024 and troughed at -$1.1 billion in Q2 2023.
- A 5-year average of -$45.9 million and a median of $37.8 million in 2025 frame the typical range for EBT.
- The sharpest annual moves came in 2023 and 2025: EBT sank 2100.97% in 2023, then jumped 291.62% in 2025.
- Over 5 years, EBT stood at $72.3 million in 2022, then slumped by 371.46% to -$196.2 million in 2023, then jumped by 164.17% to $125.9 million in 2024, then slumped by 227.65% to -$160.7 million in 2025, then jumped by 140.56% to $65.2 million in 2026.
- According to Business Quant data, EBT over the past three periods registered $65.2 million, -$160.7 million, and $68.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 689.68 Mn | 610.55 Mn | - | 73.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.73 Mn |
| Mar 31, 2026 | 65.17 Mn |
| Dec 31, 2025 | -160.70 Mn |
| Sep 30, 2025 | 68.02 Mn |
| Jun 30, 2025 | 37.82 Mn |
| Mar 31, 2025 | -36.27 Mn |
| Dec 31, 2024 | 125.89 Mn |
| Sep 30, 2024 | 17.37 Mn |
| Jun 30, 2024 | 18.88 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Dec 31, 2023 | -196.17 Mn |
| Sep 30, 2023 | 31.93 Mn |
| Jun 30, 2023 | -1.08 Bn |
| Mar 31, 2023 | 65.86 Mn |
| Dec 31, 2022 | 72.27 Mn |
| Sep 30, 2022 | 69.91 Mn |
| Jun 30, 2022 | 53.79 Mn |
| Mar 31, 2022 | 56.47 Mn |
| Dec 31, 2021 | 46.26 Mn |
| Sep 30, 2021 | 59.67 Mn |